Detalles de la búsqueda
1.
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.
BMC Cancer
; 21(1): 1238, 2021 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794412
Resultados
1 -
1
de 1
1
Próxima >
>>